Dr. David Gordon Schall, MD Otolaryngology - Otology & Neurotology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Attn: Mchk-dsh, Tamc, HI 96859 Phone: 808-433-3169 Fax: 808-433-9033 |
News Archive
Humana Inc. announced today that it has completed its previously announced acquisition of Arcadian Management Services, an Oakland, Calif.-based company that, through its affiliates, operates Medicare Advantage HMO plans.
Rotech Healthcare Inc. announced today that the company intends to offer, subject to market and other conditions, $225 million in aggregate principal amount of Senior Secured Notes due 2015.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
Medivation, Inc. and Pfizer Inc. today announced results from the CONCERT trial, which is a Phase 3 trial that evaluated dimebon (latrepirdine) when added to ongoing treatment with donepezil HCL tablets in patients with mild-to-moderate Alzheimer's disease.
Asthma sufferers in Australia have been warned about a bad cold and flu season ahead. 58 percent of the susceptible population is already experiencing asthma attacks since the start of the season according to The National Asthma Council Australia (NACA) on Monday. They went on to say that nearly half of this population is still not vaccinated against seasonal flu.
› Verified 8 days ago